Lorena Alonso-Alconada
Overview
Explore the profile of Lorena Alonso-Alconada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herrero C, Ferreiros A, Perez-Fentes D, Leon-Mateos L, Lopez-Lopez R, Abal M, et al.
Biomedicines
. 2023 Feb;
11(2).
PMID: 36830940
The two most developed biomarkers in liquid biopsy (LB)-circulating tumor cells and circulating tumor DNA-have been joined by the analysis of extracellular vesicles (EVs). EVs are lipid-bilayer enclosed structures released...
2.
Casas-Arozamena C, Otero-Cacho A, Carnero B, Almenglo C, Aymerich M, Alonso-Alconada L, et al.
Sci Rep
. 2021 Dec;
11(1):23231.
PMID: 34853364
Homing of circulating tumour cells (CTC) at distant sites represents a critical event in metastasis dissemination. In addition to physical entrapment, probably responsible of the majority of the homing events,...
3.
Herrero C, Brea J, Perez-Diaz A, Cuadrado E, Ferreno N, Moiola C, et al.
Biomed Pharmacother
. 2021 May;
140:111744.
PMID: 34049223
Endometrial cancer (EC) is the most common neoplasm of the female reproductive tract in the developed world. Patients usually are diagnosed in early stage having a good prognosis. However, up...
4.
Gil-Moreno A, Alonso-Alconada L, Diaz-Feijoo B, Domingo S, Vilar A, Hernandez A, et al.
Gynecol Oncol
. 2021 Apr;
161(3):681-686.
PMID: 33795131
Objective: Despite radical surgery and chemotherapy, most patients with ovarian cancer die due to disease progression. M-Trap is an implantable medical device designed to capture peritoneal disseminated tumor cells with...
5.
Alonso-Alconada L, de la Fuente A, Santacana M, Ferreiros A, Lopez-Lopez R, Matias-Guiu X, et al.
Dis Model Mech
. 2020 Aug;
13(6).
PMID: 32764154
Metastasis is facilitated by the formation of pre-metastatic niches through the remodelling of the extracellular matrix (ECM) promoted by haematopoietic and stromal cells. The impact of these primed sites is...
6.
Abreu M, Cabezas-Sainz P, Alonso-Alconada L, Ferreiros A, Mondelo-Macia P, Lago-Leston R, et al.
Cells
. 2020 May;
9(5).
PMID: 32423054
Background: Recent studies showed a relevant role of hematogenous spread in ovarian cancer and the interest of circulating tumor cells (CTCs) monitoring as a prognosis marker. The aim of the...
7.
Casas-Arozamena C, Diaz E, Moiola C, Alonso-Alconada L, Ferreiros A, Abalo A, et al.
J Clin Med
. 2020 Feb;
9(2).
PMID: 32098121
The incidence and mortality of endometrial cancer (EC) have risen in recent years, hence more precise management is needed. Therefore, we combined different types of liquid biopsies to better characterize...
8.
Mariscal J, Fernandez-Puente P, Calamia V, Abalo A, Santacana M, Matias-Guiu X, et al.
J Proteome Res
. 2018 Dec;
18(3):1043-1053.
PMID: 30585730
Endometrial cancer (EC) is the most frequent gynecological cancer. Tumor dissemination affecting ∼20% of EC patients is characterized at the primary carcinoma by epithelial-to-mesenchymal transition (EMT) associated with myometrial infiltration....
9.
Devis L, Martinez-Garcia E, Moiola C, Quiles M, Arbos M, Stirbat T, et al.
Oncotarget
. 2018 Apr;
9(24):16648-16664.
PMID: 29682175
Endometrial cancer (EC) is the sixth deadliest cancer in women. The depth of myometrial invasion is one of the most important prognostic factors, being directly associated with tumor recurrence and...
10.
Vidal Insua Y, De La Camara J, Brozos Vazquez E, Fernandez A, Vazquez Rivera F, Silva M, et al.
Int J Mol Sci
. 2017 Jun;
18(6).
PMID: 28608814
Colorectal cancer (CRC) is one of the major causes of cancer-related deaths. Early detection of tumor relapse is crucial for determining the most appropriate therapeutic management. In clinical practice, computed...